DeHeng Assisted AGIBOT in Completing Over 100 Million Yuan Series A Financing

2024-08-27

Recently, AGIBOT Medical Technology (Suzhou) Co., Ltd. announced the signing of a Series A financing round exceeding RMB 100 million. The round was led by Cenova Ventures, with additional investment from Hengdian Capital and existing shareholders, including Oriza Seed, Sherpa Healthcare Partners, and Suzhou Yihe Private Equity Management Co., Ltd. The funds will be used to accelerate AGIBOT’s innovation, research and development, mass production, and commercialization efforts.

As the legal advisor for this transaction, the DeHeng team, led by partner Zhang Lei and with primary support from lawyers Fang Wen and Shang Shuaili, represented AGIBOT in document review, communication, and negotiations related to the transaction.